<DOC>
	<DOCNO>NCT03081572</DOCNO>
	<brief_summary>This small observational study aim observe difference platelet function HIV patient abacavir versus tenofovir base anti-HIV drug . There correlation platelet activation cardiovascular disease- study act pilot see platelet activation among abacavir user may explain correlation abacavir cardiovascular disease HIV positive patient . This study enroll 44 participant total ; 22 abacavir-based treatment , 22 tenofovir-based treatment . There one study visit include blood draw , physical assessment , review medical history .</brief_summary>
	<brief_title>Platelet Function Abacavir Tenofovir</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Blood Platelet Disorders</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>HIV positive Stable antiretroviral regimen &gt; 3months contain either abacavir tenofovir Suppressed HIV viral load Current cigarette smoking Preexisting platelet disorder current recent ( last 6 month ) antiplatelet therapy pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>